Modulatory effects of l-carnitine plus l-acetyl-carnitine on neuroendocrine control of hypothalamic functions in functional hypothalamic amenorrhea (FHA)

References

• Batrinos ML, Panitsa-Faflia C, Courcoutsakis N, Chatzipavlou V. Incidence, type, and etiology of menstrual disorders in the age group 12–19 years. Adolesc Pediatr Gynecol 1990;3:149–53.
   Google Scholar
• Fourman LT, Fazeli PK. Neuroendocrine causes of amenorrhea – an update. J Clin Endocrinol Metab 2015;100:812–24.
   PubMed Web of Science ®Google Scholar
• Klein DA, Poth MA. Amenorrhea: an approach to diagnosis and management. Am Fam Physician 2013;87:781–8.
   PubMed Web of Science ®Google Scholar
• Genazzani AD, Despini G, Chierchia E, et al. Pharmacological and integrative treatment of stress-induced hypothalamic amenorrhea. In: Genazzani AR, Tarlatzis BC, eds. Frontiers in gynecological endocrinology: ovarian function and reproduction – from needs to possibilities, ISGE series. Vol. 3. Switzerland: Springer Int Publ.; 2015:69–84.
   Google Scholar
• Meczekalski B, Podfigurna-Stopa A, Warenik-Szymankiewicz A, Genazzani AR. Functional hypothalamic amenorrhea: current view on neuroendocrine aberrations. Gynecol Endocrinol 2008;24:4–11.
   PubMed Web of Science ®Google Scholar
• Frisch RE, McArthur JW. Menstrual cycles: fatness as a determinant of minimum weight for height necessary for their maintenance or onset. Science 1974;185:949–51.
   PubMed Web of Science ®Google Scholar
• Veldhuis JD, Evans WS, Demers LM, et al. Altered neuroendocrine regulation of gonadotropin secretion in women distance runners. J Clin Endocrinol Metab 1985;61:557–62.
   PubMed Web of Science ®Google Scholar
• Cameron JL, Helmreich DL, Schreihofer DA. Modulation of reproductive hormone secretion by nutritional intake: stress signals versus metabolic signals. Hum Reprod 1993;8:162–7.
   PubMed Web of Science ®Google Scholar
• Facchinetti F, Fava M, Fioroni L, et al. Stressful life events and affective disorders inhibit pulsatile LH secretion in hypothalamic amenorrhea. Psychoneuroendocrinology 1993;18:397–404.
   PubMed Web of Science ®Google Scholar
• Genazzani AD, Meczekalski B, Podfigurna-Stopa A, et al. Estriol administration modulates luteinizing hormone secretion in women with functional hypothalamic amenorrhea. Fertil Steril 2012;97:483–8.
   PubMed Web of Science ®Google Scholar
• Genazzani AD, Gastaldi M, Petraglia F, et al. Naltrexone administration modulates the neuroendocrine control of luteinizing hormone secretion in hypothalamic amenorrhoea. Hum Reprod 1995;10:2868–71.
   PubMed Web of Science ®Google Scholar
• Genazzani AD, Stomati M, Bersi C, et al. Pivagabine decreases stress-related hormone secretion in women with hypothalamic amenorrhea. J Endocrinol Invest 2000;23:526–32.
   PubMed Web of Science ®Google Scholar
• Genazzani AD, Lanzoni C, Ricchieri F, et al. Acetyl-L-carnitine (ALC) administration positively affects reproductive axis in hypogonadotropic women with functional hypothalamic amenorrhea. J Endocrinol Invest 2011;34:287–91.
   PubMed Web of Science ®Google Scholar
• American Psychiatric A. Diagnostic and statistical manual of mental disorders. 4th ed. Washington (DC): American Psychiatric Association; 1995.
   Google Scholar
• Genazzani AD, Petraglia F, Benatti R, et al. Luteinizing hormone (LH) secretory burst duration is independent from LH, prolactin, or gonadal steroid plasma levels in amenorrheic women. J Clin Endocrinol Metab 1991;72:1220–5.
   PubMed Web of Science ®Google Scholar
• Genazzani AD, Petraglia F, Fabbri G, et al. Evidence of luteinizing hormone secretion in hypothalamic amenorrhea associated with weight loss. Fertil Steril 1990;54:222–6.
   PubMed Web of Science ®Google Scholar
• Genazzani AD, Petraglia F, Pianazzi F, et al. The concomitant release of androstenedione with cortisol and luteinizing hormone pulsatile releases distinguishes adrenal from ovarian hyperandrogenism. Gynecol Endocrinol 1993;7:33–41.
   PubMed Web of Science ®Google Scholar
• Genazzani AD. Neuroendocrine aspects of amenorrhea related to stress. Pediatr Endocrinol Rev 2005;2:661–8.
   PubMedGoogle Scholar
• Genazzani AD, Petraglia F, Algeri I, et al. Acetyl-L-carnitine as possible drug in the treatment of hypothalamic amenorrhea. Acta Obstet Gynecol Scand 1991;70:487–92.
   PubMed Web of Science ®Google Scholar
• Rebouche CJ. Kinetics, pharmacokinetics, and regulation of L-carnitine and acetyl-L-carnitine metabolism. Ann N Y Acad Sci 2004;1033:30–41.
   PubMed Web of Science ®Google Scholar
• Bidzinska B, Petraglia F, Angioni S, et al. Acetyl-L-carnitine effect on pituitary and plasma beta-endorphin responsiveness to different chronic intermittent stressors. J Neuroendocrinol 1993;5:151–5.
   PubMed Web of Science ®Google Scholar
• Bidzinska B, Petraglia F, Angioni S, et al. Effect of different chronic intermittent stressors and acetyl-l-carnitine on hypothalamic beta-endorphin and GnRH and on plasma testosterone levels in male rats. Neuroendocrinology 1993;57:985–90.
   PubMed Web of Science ®Google Scholar
• Pettegrew JW, Levine J, McClure RJ. Acetyl-L-carnitine physical-chemical, metabolic, and therapeutic properties: relevance for its mode of action in Alzheimer’s disease and geriatric depression. Mol Psychiatry 2000;5:616–32.
   PubMed Web of Science ®Google Scholar
• Stark R, Reichenbach A, Andrews ZB. Hypothalamic carnitine metabolism integrates nutrient and hormonal feedback to regulate energy homeostasis. Moll Cell Endocrinol 2015;418:9–16.
   PubMed Web of Science ®Google Scholar
• Pocai A, Obici S, Schwartz GJ, Rossetti L. A brain–liver circuit regulates glucose homeostasis. Cell Metab 2005;1:53–61.
   PubMed Web of Science ®Google Scholar
• Humphries LL, Adams LJ, Eckfeldt JH, et al. Hyperamylasemia in patients with eating disorders. Ann Intern Med 1987;106:50–2.
   PubMed Web of Science ®Google Scholar
• Aysan E, Sahin F, Telci D, et al. Body weight reducing effect of oral boric acid intake. Int J Med Sci 2011;8:653–8.
   PubMed Web of Science ®Google Scholar